New real-world data from over 4,900 women reveals that hormonal variability across menstrual cycles is far more common than previously understood, and far more often missed. Dr. Amy Divaraniya breaks down what the research means for you.

New real-world data from over 4,900 women reveals that hormonal variability across menstrual cycles is far more common than previously understood, and far more often missed. Dr. Amy Divaraniya breaks down what the research means for you.
If you have ever tracked your cycle carefully and noticed that things feel completely different from one month to the next, you are not imagining it. And you are not alone.
For years, women have been told that a "regular" cycle means a healthy one. If your period shows up somewhere between 21 and 35 days, the assumption is that everything is working as it should. But that single data point, the date your period arrives, tells us very little about what is actually happening hormonally throughout your cycle.
I have spent years thinking about this problem. And new research we recently presented at the HHS National Conference on Women's Health puts real numbers behind what so many women already sense: hormonal variability across cycles is not the exception. It is the norm.
What "Irregular" Actually Means
When most people hear "irregular cycle," they picture missed periods or wildly unpredictable timing. But hormonal irregularity runs much deeper than what a calendar can capture.
Your menstrual cycle is driven by a carefully choreographed sequence of hormones. Estrogen rises to trigger ovulation. Luteinizing hormone (LH) surges to release the egg. Then progesterone rises in the luteal phase to support the second half of your cycle. When any part of that sequence is off, you may feel it, in your energy, your mood, your sleep, your skin, even when your period arrives right on schedule.
This is the piece the conversation around "irregular cycles" has been missing. A normal cycle length tells you very little about whether your hormones are actually doing what they should be doing inside that window.
What the Data Actually Shows
Our research analyzed 3,457 menstrual cycles across nearly 5,000 women using Oova's at-home hormone monitoring platform, which measures LH, progesterone (PdG), and estrogen (E3G) quantitatively over time. You can read the full poster on our research page. Here is what we found.
Nearly 1 in 5 cycles did not confirm ovulation.
Even when an LH surge was detected, the signal most period trackers use to confirm ovulation, 19.2% of those cycles showed no biochemical confirmation that ovulation actually occurred. An LH surge is necessary but not sufficient. Without progesterone rising afterward, ovulation has not been completed. This is called an anovulatory cycle, and most women tracking their cycles have no idea it is happening.
For women with PCOS, anovulatory cycles are especially common, and especially likely to go undetected. A standard ovulation predictor kit may show an LH surge, but PCOS frequently produces multiple LH peaks without a true ovulatory event. Without progesterone confirmation, that distinction is invisible.
More than half of ovulatory cycles showed suboptimal progesterone.
Among cycles where ovulation was confirmed, 51% showed insufficient progesterone elevation in the luteal phase, the two weeks between ovulation and your period. Progesterone in this phase matters enormously. It supports the uterine lining, regulates mood, supports sleep, and plays a critical role in early pregnancy. When it falls short, women often feel it: premenstrual spotting, a short luteal phase, low mood, fatigue.
This pattern, known as luteal phase defect, is one of the most frequently missed findings in routine care. A standard blood test taken at a single point in time will often miss it entirely. If you have ever experienced spotting before your period and wondered why, suboptimal luteal progesterone may be part of the answer.
Nearly two-thirds of women showed variability from cycle to cycle.
Among women who tracked multiple cycles, 61.5% showed inconsistency in ovulation occurrence or luteal progesterone patterns from one cycle to the next. Even if one cycle looks fine, the next one might not. A single cycle, which is often all that gets evaluated in a clinical setting, gives you an incomplete picture at best.
This finding explains why so many women feel that their symptoms shift month to month without any clear reason. It also means that being told "your labs came back normal" after a single test is not the same as being told your hormones are functioning well across time.
If You Have PCOS or Endometriosis
For women living with PCOS or endometriosis, the patterns described above are not abstract. They are often the daily reality behind symptoms that are frequently minimized or misattributed.
PCOS is the most common hormonal disorder in reproductive-age women, and irregular ovulation is one of its defining features. But "irregular" in this context rarely means "obviously absent." It often means that ovulation happens unpredictably, sometimes present, sometimes not, sometimes producing an LH surge without completing the ovulatory process. This is exactly the kind of variability that a calendar app will not catch and a single clinic visit will not reveal.
For women with endometriosis, the luteal phase is often where the dysfunction concentrates. Suboptimal progesterone in the second half of the cycle can worsen inflammation, contribute to premenstrual symptoms, and affect the uterine environment in ways that compound the challenges endometriosis already creates. If your premenstrual symptoms feel disproportionate to what your labs show, cycle-to-cycle progesterone monitoring may offer a clearer picture than a one-time blood draw.
Both conditions share a common frustration: being told everything looks normal when something clearly is not. The research here helps explain why. The tools most commonly used to assess cycle health were not designed to detect the kind of longitudinal variability that makes these conditions so difficult to manage. If you have PCOS specifically, confirming ovulation goes beyond detecting an LH surge.
If Your Cycles Are Changing as You Get Older
If you are in your late 30s or 40s and have started noticing that your cycles feel less predictable, shorter, longer, heavier, or just different, you are likely experiencing the early hormonal shifts of perimenopause, even if no one has named it that yet.
Perimenopause is not a single event. It is a transition that can span a decade, during which the hormonal patterns that once governed your cycle begin to fluctuate more widely. Ovulation becomes less consistent. Progesterone production, which depends on successful ovulation, becomes less reliable. The result is often a cycle that looks roughly normal on a calendar but feels increasingly erratic in ways that are hard to articulate in a 15-minute appointment.
This is one of the most underdiagnosed phases of women's hormonal health. Because FSH and estradiol, the hormones most commonly tested for menopause, can appear normal for years during perimenopause, women are frequently told their labs are fine when what they are experiencing is real, measurable cycle-to-cycle variability. The data from our research captures exactly this dynamic: variability that only becomes visible when you track hormones across multiple cycles, not just once.
If your symptoms have changed and your provider's answer has been "your labs are normal," longitudinal hormone monitoring may give you, and your provider, information that a single snapshot cannot. You can also learn more about what ovulation actually looks like during perimenopause, since it becomes far less predictable during this transition.
Why This Gets Missed
The way we currently assess menstrual health was not designed to detect this kind of variability.
Calendar-based period trackers tell you when your period arrived and predict when the next one will. They do not measure hormones. Ovulation predictor kits detect an LH surge but cannot confirm whether ovulation was completed or whether progesterone rose adequately afterward. A blood test at a single clinic visit captures a snapshot of one moment in one cycle, useful, but limited. As we explore in our piece on day 3 testing versus continuous monitoring, the same problem applies across the lifespan.
None of these tools were designed to monitor hormones longitudinally, across multiple cycles, in the real world. And so a meaningful proportion of hormonal dysfunction goes undetected, not because women are not paying attention, but because the tools were not built to find it.
This is exactly why the menstrual cycle has been described as a vital sign. A vital sign, by definition, requires ongoing monitoring. You would not take your blood pressure once and consider it settled. The same logic should apply here.
So Is My Cycle "Normal"?
Here is what I want you to take from this research: variability is not a character flaw in your body. It is how cycles actually work.
Hormones fluctuate. The same person can have an ovulatory cycle with healthy progesterone one month and an anovulatory cycle or a short luteal phase the next. This is not a failure. It is biological reality, and it becomes meaningful information when you can actually see it.
The question we should be asking is not "is my cycle regular?" but "what is my hormonal pattern across cycles, and what might it be telling me?"
If you have ever been told your labs are normal while feeling that something is clearly off, whether you have a known diagnosis like PCOS or endometriosis, whether you are navigating the early changes of perimenopause, or whether you simply know your body well enough to know something has shifted, this research may explain why. Single-timepoint hormone testing in a single cycle will miss the kinds of variability that only become visible over time.
What Longitudinal Monitoring Changes
When we track hormones across multiple cycles, patterns emerge that would otherwise be invisible: consistent anovulation, recurrent luteal phase defect, cycle-to-cycle progesterone swings. These patterns have real implications, for fertility, for managing chronic hormonal conditions, for navigating hormonal transitions, and for how women understand and advocate for their own bodies in clinical settings.
Understanding your progesterone levels across cycles, not just at a single moment, is one of the most powerful things you can do for your health. The data gives you language. Language gives you agency.
This is not about alarm. It is about information. The more you know about what your hormones are doing across cycles, the better equipped you are to have meaningful conversations with your provider, understand your symptoms in context, and catch potential issues early, before they become harder to address.
The Bigger Picture
We are at a moment in women's health where the conversation is finally opening up. Women are asking harder questions. Providers are beginning to listen differently. Research, including the work we are doing at Oova, is starting to fill in the gaps that decades of underinvestment left behind.
Hormonal variability across menstrual cycles is not a niche issue. It affects women managing PCOS, navigating the unpredictability of endometriosis, moving through the early shifts of perimenopause, and the many more who simply sense that something is off without yet having a name for it. The fact that most of us have no language for it, and no tools to see it, is a gap worth closing.
Your cycle is not just a date on a calendar. It is a window into your hormonal health. You deserve the tools to actually look through it.
Frequently Asked Questions
Why does my cycle feel different every month?
Cycle-to-cycle hormonal variability is common and often goes undetected. Research shows that nearly two-thirds of women show inconsistency in ovulation or luteal progesterone from one cycle to the next, meaning what happens in one cycle is not necessarily predictive of the next.
Can you have a period without ovulating?
Yes. Anovulatory cycles, cycles in which ovulation does not fully occur, can still produce a bleed that looks like a normal period. In our research, nearly 1 in 5 cycles with an LH surge showed no biochemical confirmation of ovulation. This is especially common in women with PCOS.
What is a luteal phase defect?
A luteal phase defect refers to insufficient progesterone production in the second half of your cycle, after ovulation. It can cause symptoms like premenstrual spotting, a shortened cycle, low mood, and poor sleep, and is frequently missed by single-timepoint blood testing.
How do I know if my irregular cycles are related to perimenopause?
Perimenopause can begin years before your last period, often in the late 30s or 40s, and standard hormone tests frequently appear normal during this transition. Cycle-to-cycle changes in ovulation patterns and luteal progesterone are often among the earliest signs. If your cycles have changed and your labs are "normal," longitudinal monitoring may reveal what a single test cannot.
How is Oova different from a standard ovulation predictor kit?
Standard OPKs detect the presence of an LH surge but cannot confirm whether ovulation was completed or whether progesterone rose adequately afterward. Oova measures LH, estrogen (E3G), and progesterone (PdG) quantitatively across your cycle, providing biochemical confirmation of ovulation and luteal phase adequacy over time.
About the author

Sources
- Bull JR, Rowland SP, Scherwitzl EB, Scherwitzl R, Danielsson KG, Harper J. Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. npj Digital Medicine. 2019;2(1):83. https://doi.org/10.1038/s41746-019-0152-7
- Jordan J, Craig K, Clifton DK, Soules MR. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility. 1994;62(1):54–62. https://doi.org/10.1016/S0015-0282(16)56831-6
- Schliep KC, Mumford SL, Hammoud AO, et al. Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. Human Reproduction. 2014;29(6):1305–1314. https://doi.org/10.1093/humrep/deu050
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction. 2004;19(1):41–47. https://doi.org/10.1093/humrep/deh098
- Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertility and Sterility. 2012;98(3):511–519. https://doi.org/10.1016/j.fertnstert.2012.06.029
- Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. Journal of Clinical Endocrinology & Metabolism. 2005;90(11):6106–6112. https://doi.org/10.1210/jc.2005-1374
- American College of Obstetricians and Gynecologists. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Committee Opinion No. 651. Obstetrics & Gynecology. 2015;126(6):e143–e146. https://doi.org/10.1097/AOG.0000000000001215
About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.


